Product Information
PREZISTA 800 MG TABLET is a brand product labeled by Janssen Products LP, priced at $70.1073 per EA under NDC 59676056630. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 23, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the darunavir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
800 mg/1
Manufacturer
Janssen Products LPNDC
59676056630
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DARUNAVIR ETHANOLATEApproval Type
New Drug (NDA)
FDA Application
NDA021976FDA Approved
6/23/2006
TE Code
AB
On Market Since
11/9/2012
Pharmacological Classes
Price Statistics
The NADAC for PREZISTA 800 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 100.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $70.1073 per EA |
|---|---|
| All-time high | $70.2056 (Feb 11, 2026) |
| All-time low | $35.0136 (Nov 28, 2013) |
| 52-week high | $70.2056 |
| 52-week low | $69.9909 |
| Median price | $57.2785 |
| Average price | $55.8383 |
| Largest weekly change | +7.9% (Jan 10, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Products LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
darunavir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Protease Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREZISTA 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PREZISTA 800 MG TABLET, manufactured by Janssen Products LP, is $70.1073 per EA (NDC 59676056630), effective Sep 30, 2026.
How has the price of PREZISTA 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for PREZISTA 800 MG TABLET has risen 100.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREZISTA 800 MG TABLET?
Since Nov 28, 2013, the NADAC for PREZISTA 800 MG TABLET has ranged from a low of $35.0136 (Nov 28, 2013) to a high of $70.2056 (Feb 11, 2026), with a median of $57.2785 per EA.
Are there cheaper alternatives to PREZISTA 800 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DARUNAVIR 800 MG TABLET, is $2.3819 per EA — about 97% below PREZISTA 800 MG TABLET.
Who manufactures PREZISTA 800 MG TABLET?
PREZISTA 800 MG TABLET (NDC 59676056630) is labeled by Janssen Products LP, and CMS classifies it as a brand product.